MD Medical's total revenue for the first 9 months of 2026 increased by 27% year-on-year to 39.2 billion rubles. This is stated in the company's message.
Comparable revenue (LFL) increased by 11.9% to RUB 34.547 billion. Revenue from Moscow hospitals increased by 18.4% to 16.46 billion rubles, while revenue from regional hospitals increased by 21.3% to 10 billion rubles. Revenue of outpatient clinics in Moscow and the Moscow Region increased by 17.8% to 3.4 billion rubles, while revenue of outpatient clinics in other regions increased by 60.6% to 9.22 billion rubles.
The total amount of capital expenditures amounted to 3.45 billion rubles.
MD Medical Group (Mother and Child Group) operates in the Russian market of private medical services.
The company unites 97 medical institutions, including 15 multidisciplinary hospitals and 82 outpatient clinics with a presence in 35 regions of the Russian Federation.
The authorized capital of the company is 75.125 million ordinary shares with a nominal value of 7.169 rubles.
As of December 31, 2025, the controlling stake (69.7%), as well as the beneficial owner, is Mark Kurzer.
Revenue of MD Medical Group Investments (TIN 3900026494) according to RAS for 2025 fell by 60.4% to 6.25 billion rubles. compared to a year earlier. Net profit decreased by 62.1% to RUB 5.96 billion.
MD Medical Group Investments' net profit for 2025 under IFRS increased by 8.5% year-on-year to RUB 11.035 billion from RUB 10.175 billion. Revenue increased by 31.2% to 43.455 billion rubles from 33.122 billion rubles, EBITDA increased by 24.4% to 13.289 billion rubles. 10.681 billion rubles.
MD Medical Group's profit under IFRS for the first half of 2026 increased by 5% to 5.3 billion rubles from 5.06 billion rubles a year earlier. Revenue increased by 29% to 24.8 billion rubles from 19.26 billion rubles, gross profit — by 31% to 10.05 billion rubles from 7.65 billion rubles.
